Drug Shortage Report for METHOTREXATE INJECTION USP

Last updated on 2025-03-25 History
Report ID 239730
Drug Identification Number 02182971
Brand name METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE 2.5G/100ML
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100ML VIAL
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2025-01-27
Estimated end date
Actual end date 2025-03-24
Shortage status Resolved
Updated date 2025-03-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2025-03-25 English Compare
v12 2025-03-24 French Compare
v11 2025-03-24 English Compare
v10 2025-03-18 French Compare
v9 2025-03-18 English Compare
v8 2025-03-11 French Compare
v7 2025-03-11 English Compare
v6 2025-01-28 English Compare
v5 2025-01-27 French Compare
v4 2025-01-27 English Compare
v3 2024-12-04 English Compare
v2 2024-10-09 French Compare
v1 2024-10-09 English Compare

Showing 1 to 13 of 13